These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 8814451)
1. Chromosome aberrations in prophylactic mastectomies from women belonging to breast cancer families. Petersson C; Pandis N; Mertens F; Adeyinka A; Ingvar C; Ringberg A; Idvall I; Bondeson L; Borg A; Olsson H; Kristoffersson U; Mitelman F Genes Chromosomes Cancer; 1996 Jul; 16(3):185-8. PubMed ID: 8814451 [TBL] [Abstract][Full Text] [Related]
2. Cytogenetic abnormalities in an in situ ductal carcinoma and five prophylactically removed breasts from members of a family with hereditary breast cancer. Teixeira MR; Pandis N; Gerdes AM; Dietrich CU; Bardi G; Andersen JA; Graversen HP; Mitelman F; Heim S Breast Cancer Res Treat; 1996; 38(2):177-82. PubMed ID: 8861836 [TBL] [Abstract][Full Text] [Related]
3. Karyotypic comparisons of multiple tumorous and macroscopically normal surrounding tissue samples from patients with breast cancer. Teixeira MR; Pandis N; Bardi G; Andersen JA; Heim S Cancer Res; 1996 Feb; 56(4):855-9. PubMed ID: 8631024 [TBL] [Abstract][Full Text] [Related]
4. The FHIT and PTPRG genes are deleted in benign proliferative breast disease associated with familial breast cancer and cytogenetic rearrangements of chromosome band 3p14. Panagopoulos I; Pandis N; Thelin S; Petersson C; Mertens F; Borg A; Kristoffersson U; Mitelman F; Aman P Cancer Res; 1996 Nov; 56(21):4871-5. PubMed ID: 8895736 [TBL] [Abstract][Full Text] [Related]
5. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011 [TBL] [Abstract][Full Text] [Related]
6. Lobulitis is a frequent finding in prophylactically removed breast tissue from women at hereditary high risk of breast cancer. Hermsen BB; von Mensdorff-Pouilly S; Fabry HF; Winters HA; Kenemans P; Verheijen RH; van Diest PJ J Pathol; 2005 Jun; 206(2):220-3. PubMed ID: 15880615 [TBL] [Abstract][Full Text] [Related]
7. Chromosome anomalies in human breast cancer: evidence for specific involvement of 1q region in lymphocyte cultures. Pathak S; Hopwood VL; Hortobagyi GN; Jackson GL; Hughes JI; Melillo D Anticancer Res; 1991; 11(3):1055-60. PubMed ID: 1888138 [TBL] [Abstract][Full Text] [Related]
8. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation. Meijers-Heijboer H; Brekelmans CT; Menke-Pluymers M; Seynaeve C; Baalbergen A; Burger C; Crepin E; van den Ouweland AW; van Geel B; Klijn JG J Clin Oncol; 2003 May; 21(9):1675-81. PubMed ID: 12721241 [TBL] [Abstract][Full Text] [Related]
9. Aesthetic outcome, patient satisfaction, and health-related quality of life in women at high risk undergoing prophylactic mastectomy and immediate breast reconstruction. Isern AE; Tengrup I; Loman N; Olsson H; Ringberg A J Plast Reconstr Aesthet Surg; 2008 Oct; 61(10):1177-87. PubMed ID: 17938010 [TBL] [Abstract][Full Text] [Related]
10. Ductal lavage findings in women with known breast cancer undergoing mastectomy. Khan SA; Wiley EL; Rodriguez N; Baird C; Ramakrishnan R; Nayar R; Bryk M; Bethke KB; Staradub VL; Wolfman J; Rademaker A; Ljung BM; Morrow M J Natl Cancer Inst; 2004 Oct; 96(20):1510-7. PubMed ID: 15494601 [TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of allele imbalance supports atypical ductal hyperplasia lesions as direct breast cancer precursors. Larson PS; de las Morenas A; Cerda SR; Bennett SR; Cupples LA; Rosenberg CL J Pathol; 2006 Jul; 209(3):307-16. PubMed ID: 16604511 [TBL] [Abstract][Full Text] [Related]
12. Chromosome alterations associated with positive and negative lymph node involvement in breast cancer. Wuicik L; Cavalli LR; Cornélio DA; Schmid Braz AT; Barbosa ML; Lima RS; Urban CA; Bleggi Torres LF; Ribeiro EM; Cavalli IJ Cancer Genet Cytogenet; 2007 Mar; 173(2):114-21. PubMed ID: 17321326 [TBL] [Abstract][Full Text] [Related]
13. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations. Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145 [TBL] [Abstract][Full Text] [Related]
14. [Women with hereditary risk of breast cancer: consensus of surgical representatives of study groups for hereditary tumors regarding intensive monitoring, diagnosis and preventive resection]. van Geel AN; Rutgers EJ; Vos-Deckers GC; de Vries J; Wobbes T Ned Tijdschr Geneeskd; 1997 May; 141(18):874-7. PubMed ID: 9273451 [TBL] [Abstract][Full Text] [Related]
15. Prophylactic bilateral mastectomy: patterns of practice. Metcalfe KA; Goel V; Lickley L; Semple J; Narod SA Cancer; 2002 Jul; 95(2):236-42. PubMed ID: 12124821 [TBL] [Abstract][Full Text] [Related]
16. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group. Metcalfe KA; Lubinski J; Ghadirian P; Lynch H; Kim-Sing C; Friedman E; Foulkes WD; Domchek S; Ainsworth P; Isaacs C; Tung N; Gronwald J; Cummings S; Wagner T; Manoukian S; Møller P; Weitzel J; Sun P; Narod SA; J Clin Oncol; 2008 Mar; 26(7):1093-7. PubMed ID: 18195327 [TBL] [Abstract][Full Text] [Related]
17. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. Rebbeck TR; Friebel T; Lynch HT; Neuhausen SL; van 't Veer L; Garber JE; Evans GR; Narod SA; Isaacs C; Matloff E; Daly MB; Olopade OI; Weber BL J Clin Oncol; 2004 Mar; 22(6):1055-62. PubMed ID: 14981104 [TBL] [Abstract][Full Text] [Related]
18. [Cytogenetic findings in ductal carcinoma of the breast]. Rojas-Atencio A; González L; Urdaneta K; Soto-Alvarez M; Prieto-Carrasquero M; Fulcado W; Quintero M; Boscán A; Alvarez Nava F Invest Clin; 1999 Sep; 40(3):179-89. PubMed ID: 10531751 [TBL] [Abstract][Full Text] [Related]
19. A population-based study of bilateral prophylactic mastectomy efficacy in women at elevated risk for breast cancer in community practices. Geiger AM; Yu O; Herrinton LJ; Barlow WE; Harris EL; Rolnick S; Barton MB; Elmore JG; Fletcher SW Arch Intern Med; 2005 Mar; 165(5):516-20. PubMed ID: 15767526 [TBL] [Abstract][Full Text] [Related]
20. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands. Ahmadian M; Wistuba II; Fong KM; Behrens C; Kodagoda DR; Saboorian MH; Shay J; Tomlinson GE; Blum J; Minna JD; Gazdar AF Cancer Res; 1997 Sep; 57(17):3664-8. PubMed ID: 9288768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]